List of bibliographic references indexed by Patent report
Number of relevant bibliographic references: 11.
| Ident. | Authors (with country if any) | Title |
|---|
| 001261 (1995) |
| Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector |
| 001262 (1995) |
| Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease |
| 001263 (1995) |
| New epitope-bearing portions of Entamoeba histolytica ; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine |
| 001265 (1995) |
| Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine |
| 001317 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 001321 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 001323 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 001326 (1993) |
| New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production |
| 001327 (1993) |
| Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine |
| 001514 (1988) |
| New avirulent Salmonella-Escherichia coli hybrid strains useful in live oral vaccine against enteric diseases including cholera |
| 001628 (1985) |
| Patent report |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Patent report"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i \
-Sk "Patent report" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Teeft.i
|clé= Patent report
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021 |  |
